ACN vs AEP Stock Comparison
Scores Breakdown
| Metric | ACN | AEP |
|---|---|---|
| 📈 Growth | 22/30 | 22/30 |
| 💰 Profitability | 18/20 | 16/20 |
| 🏦 Financial Health | 18/20 | 12/20 |
| 💵 Valuation | 16/20 | 14/20 |
| ⚠️ Risk (lower is better) | 4/10 | 7/10 |
| Overall Score | 80/100 | 67/100 |
Side-by-Side Summaries
| ACN Analysis | AEP Analysis |
|---|---|
📈 Growth & Financial TrajectoryOver 8 quarters, revenues moved from $16.41B (2024 Q4) to $18.72B (2026 Q3), a cumulative rise of about 14%. Net income increased from roughly $1.68B to $2.34B, up about 39%, signaling improving operating leverage as scale widens. The trend shows quarterly fluctuations but an overall positive trajectory with gradually rising profitability. 💰 Margins & Cash Flow
🛡️ Balance Sheet & Liquidity
⚠️ Key Drivers & Risks
|
📈 Growth & Financial TrajectoryThe eight quarters show revenue rising from $5.420B in 2024 Q3 to $6.020B in 2026 Q1, about a net increase of ~11%. Net income fluctuated: from $0.962B at the start to $0.903B at the end, with a peak near $1.288B in 2025 Q2. This signals a healthier top line with episodic earnings swings, ending with higher revenue but a slightly lower cumulative net income than the start. 💰 Margins & Cash FlowNet income margins averaged in the mid-teens, with notable strength around 25% in 2025 Q2. Operating cash flow tended to be positive across quarters, while investing cash flow was typically negative, reflecting ongoing capex. Cash flow from operations generally ranged in the low-to-mid billions, with an indicative average near $1.8B and occasional peaks near $2.5B. 🛡️ Balance Sheet & LiquidityAssets sit in the $110B–$118B range, with liabilities around $76B–$85B and equity roughly $27B–$33B; end-quarter figures show long-term debt near $42B–$50B. The regulated utility profile supports resilience, though leverage remains notable for the sector. ⚠️ Key Drivers & Risks
|